Compassionate use of orphan drugs | Orphanet Journal of Rare Diseases | Full Text
The EU's compassionate use mechanism for drugs. | Download Table
A case for compassionate use: When unapproved drugs are the only hope
PharmaBoardroom - Evolving Compassionate Use and Named Patient Programs Across Asia Pacific
Compassionate Use and other Managed Access Concepts - GMP Journal
PDF) Compassionate use programs in Italy: Ethical guidelines
Manufacturer's Compassionate Use Policies: Companies with Posted Policies More Than Doubled Since September 2016
Compassionate Use Programmes - Paul-Ehrlich-Institut
Compassionate use programs and the European regulatory system Filip Josephson M.D., Ph.D. Clinical Assessor. - ppt download
The Global Guide to Compassionate Use Programs
Compassionate use - EURORDIS
Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center | PLOS ONE
Compassionate Use Programmes - Paul-Ehrlich-Institut
Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program | RAPS
Compassionate Use" and the Law on Unapproved COVID-19 Drugs
Compassionate use of drugs and medical devices in the United States, the European Union and Japan - ScienceDirect
Compassionate use: Providing access to much needed treatments | Novartis
I'm Willing To Try Anything': Compassionate Use Access To Experimental Drugs And The Misguided Mission Of Right-To-Try Laws | Health Affairs
Proportion of Gaucher Patients per country receiving their treatment on... | Download Scientific Diagram
Egetis receives approval in Turkey for compassionate use of Emcitate® for MCT8 deficiency
Off-label and Compassionate use of Medications for COVID-19 Treatment
Compassionate Use and other Managed Access Concepts - GMP Journal
